AMERESCO INC-CL A (AMRC)

US02361E1082 - Common Stock

27.51  +2.37 (+9.43%)

After market: 27.625 +0.11 (+0.42%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to AMRC. AMRC was compared to 44 industry peers in the Construction & Engineering industry. Both the profitability and financial health of AMRC have multiple concerns. AMRC is valued quite expensive, but it does show an excellent growth.



3

1. Profitability

1.1 Basic Checks

In the past year AMRC was profitable.
AMRC had a positive operating cash flow in the past year.
Each year in the past 5 years AMRC has been profitable.
AMRC had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of 1.34%, AMRC perfoms like the industry average, outperforming 45.24% of the companies in the same industry.
AMRC has a Return On Equity of 5.69%. This is comparable to the rest of the industry: AMRC outperforms 50.00% of its industry peers.
AMRC's Return On Invested Capital of 2.64% is on the low side compared to the rest of the industry. AMRC is outperformed by 66.67% of its industry peers.
AMRC had an Average Return On Invested Capital over the past 3 years of 3.95%. This is significantly below the industry average of 11.66%.
Industry RankSector Rank
ROA 1.34%
ROE 5.69%
ROIC 2.64%
ROA(3y)2.71%
ROA(5y)2.89%
ROE(3y)9.47%
ROE(5y)9.94%
ROIC(3y)3.95%
ROIC(5y)3.99%

1.3 Margins

The Profit Margin of AMRC (3.18%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of AMRC has remained more or less at the same level.
Looking at the Operating Margin, with a value of 6.01%, AMRC is in line with its industry, outperforming 57.14% of the companies in the same industry.
In the last couple of years the Operating Margin of AMRC has declined.
With a Gross Margin value of 15.70%, AMRC perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
AMRC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.01%
PM (TTM) 3.18%
GM 15.7%
OM growth 3Y-4.42%
OM growth 5Y-3.97%
PM growth 3Y-4.58%
PM growth 5Y-1.24%
GM growth 3Y-0.44%
GM growth 5Y-4.06%

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AMRC is destroying value.
AMRC has more shares outstanding than it did 1 year ago.
AMRC has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, AMRC has a worse debt to assets ratio.

2.2 Solvency

AMRC has an Altman-Z score of 1.06. This is a bad value and indicates that AMRC is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.06, AMRC is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
AMRC has a Debt/Equity ratio of 1.41. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of AMRC (1.41) is worse than 78.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.41
Debt/FCF N/A
Altman-Z 1.06
ROIC/WACC0.23
WACC11.24%

2.3 Liquidity

A Current Ratio of 1.27 indicates that AMRC should not have too much problems paying its short term obligations.
With a Current ratio value of 1.27, AMRC is not doing good in the industry: 64.29% of the companies in the same industry are doing better.
AMRC has a Quick Ratio of 1.26. This is a normal value and indicates that AMRC is financially healthy and should not expect problems in meeting its short term obligations.
AMRC's Quick ratio of 1.26 is on the low side compared to the rest of the industry. AMRC is outperformed by 61.90% of its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.26

8

3. Growth

3.1 Past

AMRC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.60%, which is quite good.
Measured over the past years, AMRC shows a quite strong growth in Earnings Per Share. The EPS has been growing by 9.41% on average per year.
The Revenue has grown by 32.71% in the past year. This is a very strong growth!
AMRC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.80% yearly.
EPS 1Y (TTM)8.6%
EPS 3Y2.19%
EPS 5Y9.41%
EPS Q2Q%-17.5%
Revenue 1Y (TTM)32.71%
Revenue growth 3Y10.02%
Revenue growth 5Y11.8%
Sales Q2Q%49.45%

3.2 Future

AMRC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.89% yearly.
The Revenue is expected to grow by 13.14% on average over the next years. This is quite good.
EPS Next Y-8.59%
EPS Next 2Y15.7%
EPS Next 3Y26.16%
EPS Next 5Y22.89%
Revenue Next Year32.47%
Revenue Next 2Y21.27%
Revenue Next 3Y18.36%
Revenue Next 5Y13.14%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 27.24 indicates a quite expensive valuation of AMRC.
Compared to the rest of the industry, the Price/Earnings ratio of AMRC indicates a somewhat cheap valuation: AMRC is cheaper than 69.05% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.41, AMRC is valued at the same level.
Based on the Price/Forward Earnings ratio of 16.18, the valuation of AMRC can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AMRC indicates a rather cheap valuation: AMRC is cheaper than 83.33% of the companies listed in the same industry.
AMRC is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.69, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 27.24
Fwd PE 16.18

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AMRC is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.74

4.3 Compensation for Growth

AMRC's earnings are expected to grow with 26.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)2.89
EPS Next 2Y15.7%
EPS Next 3Y26.16%

0

5. Dividend

5.1 Amount

No dividends for AMRC!.
Industry RankSector Rank
Dividend Yield N/A

AMERESCO INC-CL A

NYSE:AMRC (1/3/2025, 7:17:36 PM)

After market: 27.625 +0.11 (+0.42%)

27.51

+2.37 (+9.43%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners103.19%
Inst Owner Change3.39%
Ins Owners7.13%
Ins Owner Change2.09%
Market Cap1.44B
Analysts79
Price Target38.3 (39.22%)
Short Float %9.39%
Short Ratio8.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-48.98%
Min EPS beat(2)-66.19%
Max EPS beat(2)-31.77%
EPS beat(4)2
Avg EPS beat(4)-15.31%
Min EPS beat(4)-66.19%
Max EPS beat(4)19.03%
EPS beat(8)2
Avg EPS beat(8)-14.83%
EPS beat(12)6
Avg EPS beat(12)-2.62%
EPS beat(16)10
Avg EPS beat(16)13.59%
Revenue beat(2)2
Avg Revenue beat(2)7.36%
Min Revenue beat(2)0.97%
Max Revenue beat(2)13.75%
Revenue beat(4)4
Avg Revenue beat(4)9.36%
Min Revenue beat(4)0.97%
Max Revenue beat(4)14.53%
Revenue beat(8)6
Avg Revenue beat(8)4.51%
Revenue beat(12)9
Avg Revenue beat(12)4.86%
Revenue beat(16)12
Avg Revenue beat(16)5.48%
PT rev (1m)0%
PT rev (3m)0.98%
EPS NQ rev (1m)0%
EPS NQ rev (3m)12.39%
EPS NY rev (1m)-1.03%
EPS NY rev (3m)-1.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.47%
Valuation
Industry RankSector Rank
PE 27.24
Fwd PE 16.18
P/S 0.86
P/FCF N/A
P/OCF 20.71
P/B 1.54
P/tB 1.69
EV/EBITDA 15.74
EPS(TTM)1.01
EY3.67%
EPS(NY)1.7
Fwd EY6.18%
FCF(TTM)-7.29
FCFYN/A
OCF(TTM)1.33
OCFY4.83%
SpS32.01
BVpS17.87
TBVpS16.32
PEG (NY)N/A
PEG (5Y)2.89
Profitability
Industry RankSector Rank
ROA 1.34%
ROE 5.69%
ROCE 3.34%
ROIC 2.64%
ROICexc 2.74%
ROICexgc 2.82%
OM 6.01%
PM (TTM) 3.18%
GM 15.7%
FCFM N/A
ROA(3y)2.71%
ROA(5y)2.89%
ROE(3y)9.47%
ROE(5y)9.94%
ROIC(3y)3.95%
ROIC(5y)3.99%
ROICexc(3y)4.12%
ROICexc(5y)4.16%
ROICexgc(3y)4.29%
ROICexgc(5y)4.36%
ROCE(3y)5%
ROCE(5y)5.05%
ROICexcg growth 3Y-18.26%
ROICexcg growth 5Y-15.15%
ROICexc growth 3Y-17.82%
ROICexc growth 5Y-14.46%
OM growth 3Y-4.42%
OM growth 5Y-3.97%
PM growth 3Y-4.58%
PM growth 5Y-1.24%
GM growth 3Y-0.44%
GM growth 5Y-4.06%
F-Score5
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 1.41
Debt/FCF N/A
Debt/EBITDA 7.24
Cap/Depr 556.73%
Cap/Sales 26.93%
Interest Coverage 0.92
Cash Conversion 38.25%
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 1.26
Altman-Z 1.06
F-Score5
WACC11.24%
ROIC/WACC0.23
Cap/Depr(3y)611.92%
Cap/Depr(5y)525.39%
Cap/Sales(3y)24.41%
Cap/Sales(5y)21.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.6%
EPS 3Y2.19%
EPS 5Y9.41%
EPS Q2Q%-17.5%
EPS Next Y-8.59%
EPS Next 2Y15.7%
EPS Next 3Y26.16%
EPS Next 5Y22.89%
Revenue 1Y (TTM)32.71%
Revenue growth 3Y10.02%
Revenue growth 5Y11.8%
Sales Q2Q%49.45%
Revenue Next Year32.47%
Revenue Next 2Y21.27%
Revenue Next 3Y18.36%
Revenue Next 5Y13.14%
EBIT growth 1Y46.21%
EBIT growth 3Y5.15%
EBIT growth 5Y7.36%
EBIT Next Year153.62%
EBIT Next 3Y52.62%
EBIT Next 5Y36.96%
FCF growth 1Y32.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y121.16%
OCF growth 3YN/A
OCF growth 5YN/A